Skip to main content
logo
Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.310
-0.030 (-2.24%)
Oct 16, 2026, 4:00 PM EDT - Market closed

Allogene Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4533084475409072,126
Market Cap Growth
60.61%-31.06%-17.32%-40.45%-57.34%-39.95%
Enterprise Value
1991412481714571,697
Last Close Price
1.311.372.133.216.2914.92

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
97.54-20300.075685.985814.6318.64
PB Ratio
1.041.051.061.061.362.32
P/TBV Ratio
1.041.051.061.061.362.32

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
42.89-11252.801803.612931.9914.87

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.180.280.220.190.150.08
Net Debt / Equity Ratio
-0.58-0.57-0.48-0.69-0.62-0.42
Net Debt / EBITDA Ratio
1.500.860.831.181.302.26
Net Debt / FCF Ratio
2.471.121.001.481.841.86
Asset Turnover
0.01-0000.10
Quick Ratio
10.557.748.2912.159.699.62
Current Ratio
10.727.938.5412.389.849.78
Return on Equity (ROE)
-42.39%-53.42%-55.13%-55.51%-43.00%-18.24%
Return on Assets (ROA)
-22.08%-26.82%-27.01%-26.84%-22.55%-9.94%
Return on Capital Employed (ROCE)
-34.80%-54.00%-50.20%-51.90%-43.70%-18.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-36.57%-62.00%-57.68%-60.59%-37.53%-8.56%
FCF Yield
-22.67%-48.60%-45.01%-44.29%-24.88%-9.70%
Buyback Yield / Dilution
-19.14%-13.25%-24.14%-9.63%-5.39%-12.84%
SEC Filings: 10-K · 10-Q